On the contrary, the decreased expression of NRP-1 in addition to SNAI1 and SEMA4A in PBMCs in the cancer cohort studied compared to healthy controls highlights their potential protective role against breast cancer. This evidence concerns the gene SEMA4A and breast carcinoma.